More on NXTC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

NextCure Inc. (NQ:NXTC)
Delayed: 2.02 -0.18 (8.18%)
Prev. Close $2.20  
Open$2.20 
52 Wk High$ 
52 Wk Low$ 
Day High$2.25 
Day Low$2.00 
P/E N/A  
EPS$ 
Volume59,376 


Jun 4, 2026 08:01 AM NXTC makes replay available for event on cancer drug trial data
Jun 4, 2026 08:00 AM NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
Jun 1, 2026 08:11 AM Form 8-K NextCure, Inc. For: Jun 01
Jun 1, 2026 08:01 AM NextCure reports positive SIM0505 trial data for gynecologic cancers
Jun 1, 2026 08:00 AM NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
May 13, 2026 04:42 PM Form SCHEDULE 13G/A NextCure, Inc. Filed by: SILVERARC CAPITAL MANAGEMENT, LLC
May 11, 2026 07:10 AM Lucid Capital Markets Starts NextCure Inc. (NXTC) at Buy
May 8, 2026 05:42 AM NextCure Inc. (NXTC) Misses Q1 EPS by 187c
May 7, 2026 04:30 PM Form 10-Q NextCure, Inc. For: Mar 31
May 7, 2026 04:22 PM Form 8-K NextCure, Inc. For: May 07
View All Articles

Entities mentioned with NXTC

View All Entities